User Auth Test Page

FDA Finds Possible Risk Of Guillain-Barre Syndrome With Pfizer’s RSV Vaccine For Older Adults

CNBC (2/24, Kimball) reported the FDA “sees a possible risk of Guillain-Barre syndrome with Pfizer’s RSV vaccine for older adults and has asked the company to conduct a safety study if the shot is approved this spring, according to agency briefing documen...

Full Article
Laboratory Leak Most Likely Origin Of Pandemic, Energy Department Says

The Wall Street Journal (2/26, A1, Strobel, Gordon, Subscription Publication) says the Department of Energy has concluded in a recent classified intelligence report that the COVID-19 pandemic most likely originated from a laboratory leak. Bloomberg (2/26,...

Full Article
Avian Flu Will Not Likely Subside In US, Experts Warn

The Wall Street Journal (2/23, A1, Thomas, Subscription Publication) reports that since February of 2022, avian flu has killed nearly 58 million farm-raised birds in the US, marking the deadliest outbreak on record and inflating the prices of turkey and e...

Full Article
Long-Acting Cabotegravir Plus Rilpivirine Noninferior To Daily Oral HIV Medication, Preferred By Most Patients, Trial Indicates

Healio (2/23, Stulpin) reports, “Long-acting cabotegravir plus rilpivirine administered every 2 months was noninferior to daily oral HIV medication and was preferred by most participants in a phase 3b randomized trial, according to data” presented at the...

Full Article
South Africa Confirms First Death Due To Cholera

Reuters (2/23, Acharya) reports, “One person with no travel history has died due to cholera in South Africa, the health department said on Thursday, as the number of confirmed cases in the country rose to five.” This “development comes on the heels of ris...

Full Article
Black, Hispanic People More Likely To Experience Long COVID-Related Symptoms, Health Problems, Study Indicates

Healio (2/23, Rhoades) reports “Black and Hispanic individuals were more likely to experience long COVID-related symptoms and health problems compared with white individuals, according to” a “retrospective cohort study.” The findings, published in the Jou...

Full Article
Moderna Makes $400M Payment To NIH For COVID-19 Vaccine Technique

The New York Times (2/23, Mueller) reports, “As Moderna racked up tens of billions of dollars in sales of its coronavirus vaccine, the company held off on paying for the rights to a chemical technique that scientists said it had borrowed from government-f...

Full Article
Financial Incentives Needed to Attract Next Generation of Laboratory Professionals

Abstract Not Available

Full Article
Interpretation of Lung Cancer Plasma EGFR Mutation Tests in the Clinical Setting: An Update With Meta-Analysis

Abstract Not Available

Full Article
A Meta-Analysis on the Association of Colibactin-Producing pks+ Escherichia coli with the Development of Colorectal Cancer

Abstract Not Available

Full Article
CDC Advisors Recommend Jynneos Vaccine For Adults At Risk Of Mpox In Future Outbreaks

USA Today (2/22, Weintraub) reports, “The mpox vaccine worked well at preventing symptoms and shortening the course of the disease...and it should continue to be used, a federal panel decided Wednesday.” The “14-member Advisory Committee on Immunization P...

Full Article
Study Using Wastewater Signals Indicates Masks Reduce COVID-19 Risk In Elementary Schools

Healio (2/22, Weldon) reports, “A study that used wastewater signals to identify cases of COVID-19 found that even a small increase in the proportion of people wearing masks at elementary schools in one California county significantly reduced the chance o...

Full Article
Flu Vaccine Effective During 2022-2023 Season, CDC Data Show

The AP (2/22, Stobbe) reports early estimates (PDF) from the CDC “suggest the flu vaccine performed well in a U.S. winter flu season that has already dissipated.” The “vaccines were more than 40% effective in preventing adults from getting sick enough fro...

Full Article
Pediatric Deaths From HIV-Related Illness In Africa Largely Preventable, Data Indicate

MedPage Today (2/22, Susman) reports, “More than half of the children who died from HIV-related illnesses in Africa were not diagnosed with HIV prior to their death, and nearly all of these deaths were preventable, data from the Child Health and Mortality...

Full Article
Long-Acting PrEP With Cabotegravir Yields Substantial Benefit In Black People, But HIV Incidence Still Higher, Study Indicates

MedPage Today (2/22, Susman) reports, “Black individuals in the U.S. taking pre-exposure prophylaxis (PrEP) for HIV had substantial benefit with long-acting cabotegravir (Apretude), a substudy of the randomized...HPTN 083 trial showed, but they still face...

Full Article
RSV Vaccine For Newborns Could Be Approved By August

ABC News (2/21, Yamada, Salzman) reports, “After decades of research, a first-of-its kind vaccine designed to protect newborns against RSV, or respiratory syncytial virus, could be approved by August.” Pfizer, maker of RSVpreF, “announced Tuesday that the...

Full Article
Mpox Often Causes Severe Illness In Patients With Advanced HIV, Researchers Say

The New York Times (2/21, Mandavilli) says, “In people with advanced H.I.V. disease, the mpox virus...often causes severe illness, with a death rate of about 15 percent, researchers reported” in a study that “analyzed the amount of H.I.V. and the number o...

Full Article
Shorter Regimen Of Bedaquiline Plus Linezolid Noninferior To Standard Treatment For Tuberculosis, Trial Finds

Healio (2/21, Stulpin) reports, “An 8-week boosted regimen of bedaquiline and linezolid was noninferior to standard 24-week treatment for tuberculosis in terms of clinical outcomes, according to the results of a phase 2-3 trial.” These results from the “o...

Full Article
Adding Sutezolid To Three-Drug Combination Appears Safe, Effective For People With Multidrug-Resistant Tuberculosis, Study Indicates

MedPage Today (2/21, Susman) reports, “Adding the oxazolidinone antibiotic sutezolid to a three-drug combination appeared to be safe and effective for people with multidrug-resistant tuberculosis (TB), according to a dose-finding phase II study.” Across “...

Full Article
Doxycycline Prophylaxis Did Not Prevent STIs Among African Cisgender Women In Trial, Results Show

MedPage Today (2/21, Susman) reports trial results showed that “doxycycline prophylaxis failed to prevent sexually transmitted infections (STIs) among African cisgender women, unlike its success among men who have sex with men.” In the “trial conducted am...

Full Article

Request a Call from Customer Relations

Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id

First Name *
Last Name *
Email *
Customer ID

FDA Finds Possible Risk Of Guillain-Barre Syndrome With Pfizer’s RSV Vaccine For Older Adults

Laboratory Leak Most Likely Origin Of Pandemic, Energy Department Says

Avian Flu Will Not Likely Subside In US, Experts Warn

Long-Acting Cabotegravir Plus Rilpivirine Noninferior To Daily Oral HIV Medication, Preferred By Most Patients, Trial Indicates

South Africa Confirms First Death Due To Cholera

Black, Hispanic People More Likely To Experience Long COVID-Related Symptoms, Health Problems, Study Indicates

Moderna Makes $400M Payment To NIH For COVID-19 Vaccine Technique

Financial Incentives Needed to Attract Next Generation of Laboratory Professionals

Interpretation of Lung Cancer Plasma EGFR Mutation Tests in the Clinical Setting: An Update With Meta-Analysis

A Meta-Analysis on the Association of Colibactin-Producing pks+ Escherichia coli with the Development of Colorectal Cancer

CDC Advisors Recommend Jynneos Vaccine For Adults At Risk Of Mpox In Future Outbreaks

Study Using Wastewater Signals Indicates Masks Reduce COVID-19 Risk In Elementary Schools

Flu Vaccine Effective During 2022-2023 Season, CDC Data Show

Pediatric Deaths From HIV-Related Illness In Africa Largely Preventable, Data Indicate

Long-Acting PrEP With Cabotegravir Yields Substantial Benefit In Black People, But HIV Incidence Still Higher, Study Indicates

RSV Vaccine For Newborns Could Be Approved By August

Mpox Often Causes Severe Illness In Patients With Advanced HIV, Researchers Say

Shorter Regimen Of Bedaquiline Plus Linezolid Noninferior To Standard Treatment For Tuberculosis, Trial Finds

Adding Sutezolid To Three-Drug Combination Appears Safe, Effective For People With Multidrug-Resistant Tuberculosis, Study Indicates

Doxycycline Prophylaxis Did Not Prevent STIs Among African Cisgender Women In Trial, Results Show